CD46 and pulmonary venoocclusive disease: Another patient with an MCP mutation, who had no recurrence of aHUS in the renal transplant, developed pulmonary veno-occlusive disease (PVOD), which led eventually to the finding of an inborn error of cobalamin metabolism, and he died 7.5 years after his first presentation [21].